Edwards Lifesciences Shares Fall as Heart-Valve Growth Slows

Edwards Lifesciences has slightly raised its annual forecasts for sales and profit, but slower-than-expected revenue growth in the company's artificial heart valves dragged its shares down.
Reuters Health Information

source https://www.medscape.com/s/viewarticle/994850?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?